Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of JTE-051 in interstitial cystitis/bladder pain syndrome
jRCT2031210042Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) comparing JTE-051 once daily with Placebo once daily (2 arms). Primary endpoint: Change from baseline in NRS average bladder pain score. Started Jun 2021; status: completed.
02
Drugs
JTE-051
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on jRCT2031210042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210042.